pfizer – The Inside Adviser

ASX halts five-session losing run to gain 0.4%

August 23, 2021 by The Inside Adviser

ASX shakes off sentiment, IT recovery, Charter Hall, Reliance deliver records The ASX200 (ASX: XJO) shook off a rare negative week to open 0.4% higher on Monday. The IT and property sectors, up...

Banks help ASX eke out narrow gain

May 4, 2021 by The Inside Adviser

Bank rally not enough, Westpac hike dividend, job ads continue to surprise The ASX200 (ASX:XJO) rose just three points to begin the week, with a powerful day from the financials sector (+1.4%)...

Pfizer’s Coronavirus vaccine – a closer look

November 16, 2020 by Contributor

A major milestone for Pfizer On 9 November 2020, Pfizer announced that its vaccine candidate, developed in collaboration with BioNTech, was more than 90 per cent effective in preventing COVID-19...

Gold, equities and active management

November 16, 2020 by The Inside Adviser

Trillion-dollar French asset manager Amundi released their November Cross Asset Strategy report last week, with gold bullion and active management among their highest conviction calls. The group is renowned for...